Re: Clinical Efficacy of Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease by Subgroups: Results from Two Large, Double-blind, Randomized, Placebo-controlled, Phase III Studies

被引:3
|
作者
Kadioglu, Ates [1 ]
Boyuk, Abubekir [1 ]
Salabas, Emre [1 ]
机构
[1] Istanbul Univ, Istanbul Fac Med, Sect Androl, Istanbul, Turkey
关键词
QUESTIONNAIRE; SAFETY;
D O I
10.1016/j.eururo.2015.07.067
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:908 / 909
页数:3
相关论文
共 50 条
  • [41] Zishenpingchan granules for the treatment of Parkinson's disease:a randomized,double-blind,placebo-controlled clinical trial
    Qing Ye
    Xiao-Lei Yuan
    Can-Xing Yuan
    Hong-Zhi Zhang
    Xu-Ming Yang
    Neural Regeneration Research, 2018, (07) : 1269 - 1275
  • [42] Zishenpingchan granules for the treatment of Parkinson's disease: a randomized, double-blind, placebo-controlled clinical trial
    Ye, Qing
    Yuan, Xiao-Lei
    Yuan, Can-Xing
    Zhang, Hong-Zhi
    Yang, Xu-Ming
    NEURAL REGENERATION RESEARCH, 2018, 13 (07) : 1269 - 1275
  • [43] A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with Fibromyalgia
    Mease, Philip J.
    Russell, I. Jon
    Arnold, Lesley M.
    Florian, Hana
    Young, James P.
    Martin, Susan A.
    Sharma, Uma
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (03) : 502 - 514
  • [44] Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting
    Hengge, UR
    Stocks, K
    Wiehler, H
    Faulkner, S
    Esser, S
    Lorenz, C
    Jentzen, W
    Hengge, D
    Goos, M
    Dudley, RE
    Gham, GR
    AIDS, 2003, 17 (05) : 699 - 710
  • [45] Apremilast for Behcet's syndrome: results from a phase III, randomized, double-blind, placebo-controlled study in a Japanese subgroup
    Kono, H.
    Dobashi, H.
    Tanaka, Y.
    Sugii, S.
    Kishimoto, M.
    Cheng, S.
    Mccue, S.
    Paris, M.
    Takeno, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (06) : S182 - S182
  • [46] Apremilast for Behcet's Syndrome: Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study in a Japanese Subgroup
    Takeno, Mitsuhiro
    Tanaka, Yoshiva
    Kono, Hajime
    Sugii, Shouji
    Kishimoto, Mitsumasa
    Chene, Sue
    McCue, Shannon
    Paris, Maria
    Dobashi, Hiroaki
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [47] Lamotrigine for treatment of pain associated with diabetic neuropathy: Results of two randomized, double-blind, placebo-controlled studies
    Vinik, Aaron I.
    Tuchman, Michael
    Safirstein, Beth
    Corder, Clinton
    Kirby, Louis
    Wilks, Kerri
    Quessy, Steve
    Blum, David
    Grainger, Joanne
    White, Jonathan
    Silver, Marianne
    PAIN, 2007, 128 (1-2) : 169 - 179
  • [48] A First Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Extracorporeal Shock Wave Therapy for the Treatment of Peyronie's Disease
    Palmieri, Alessandro
    Imbimbo, Ciro
    Longo, Nicola
    Fusco, Ferdinando
    Verze, Paolo
    Mangiapia, Francesco
    Creta, Massimiliano
    Mirone, Vincenzo
    EUROPEAN UROLOGY, 2009, 56 (02) : 363 - 369
  • [49] Clostridium histolyticum (AA4500) for the Treatment of Adhesive Capsulitis of the Shoulder: A Randomised Double-Blind, Placebo-Controlled Study for the Safety and Efficacy of Collagenase - Single Site Report
    Fitzpatrick, Jane
    Richardson, Christen
    Klaber, Ianiv
    Richardson, Martin D.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 2707 - 2713
  • [50] EFFICACY OF INTRATYMPANIC OTO-104 FOR THE TREATMENT OF MÉNIÈRE'S DISEASE: THE OUTCOME OF THREE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES
    Scarpa, Alfonso
    Carucci, Mario
    Ralli, Massimo
    De Luca, Pietro
    Salzano, Giovanni
    Viola, Pasquale
    Chiarella, Giuseppe
    Francesco, Antonio Salzano
    OTOLOGY & NEUROTOLOGY, 2024, 45 (09) : 1087 - 1088